The LifeTouch Patient Surveillance System, developed by UK company Isansys Lifecare, reportedly is the first cloud-ready product to be certified as a Class IIa medical device under the terms of Europe’s Medical Devices Directive. The CE-marked system can now be used clinically within the European Union, but company CEO Keith Errey has far greater ambitions for his device. The United States is a target market . . . as is India.
The LifeTouch system, which comprises a body-worn wireless sensor and Patient Gateway, provides continuous real-time monitoring of a patient’s key vitals in the hospital, at another care facility or in the patient’s home. Errey describes it as a “vitals-as-a-service” clinical solution that will improve patient outcomes and reduce costs, making it appealing to healthcare systems from Barcelona to Bangalore.
The affordability of the technology allows healthcare providers to leapfrog expensive conventional monitoring systems and meet the demands of India’s growing middle class, which is woefully underserved in healthcare,” says Errey.
Read the full interview of Errey on medtechinsider.com.Norbert Sparrow